Clinical Trial Update: Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating formoterol (Certihaler), tiotropium (HandiHaler), and their combination in stable chronic obstructive pulmonary disease; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Formoterol Certihaler (formoterol)
• Tiotropium HandiHaler (tiotropium)
• Tiotropium HandiHaler in Combination With Formoterol Certihaler (tiotropium/formoterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED